• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TMPRSS2-ERG 基因融合在白种人、非裔美国人和日本前列腺癌患者中的流行率和类型有显著差异。

TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.

机构信息

Department of Anatomic Pathology, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Prostate. 2011 Apr;71(5):489-97. doi: 10.1002/pros.21265. Epub 2010 Sep 28.

DOI:10.1002/pros.21265
PMID:20878952
Abstract

BACKGROUND

Prostate cancer (PCa) exhibits significant differences in prevalence and mortality among different ethnic groups. The underlying genetics is not well understood. TMPRSS2-ERG fusion is a common recurrent chromosomal aberration in PCa and is however not studied among different ethnic groups. We examined the prevalence and class of TMPRSS2-ERG gene fusion in PCa from Caucasian, African-American, and Japanese patients.

MATERIALS AND METHODS

A tissue microarray of PCa from 42 Caucasians, 64 African-Americans, and 44 Japanese patients who underwent radical prostatectomies (RP) was studied for TMPRSS2-ERG fusion using a multicolor interphase fluorescence in situ hybridization assay for ERG gene break-apart.

RESULTS

TMPRSS2-ERG gene fusion was present in 50% (21/42) of Caucasians, 31.3% (20/64) of African-Americans, and 15.9% (7/44) of Japanese (P=0.003). The gene fusion through translocation, deletion, or both occurred in 61.9% (13/21), 38.1% (8/21), and 0% (0/21) in Caucasians, 20% (4/20), 60% (12/20), and 20% (4/20) in African-Americans, and 71.4% (5/7), 28.6% (2/7), and 0% (0/7) in Japanese patients (P=0.02). A multivariate analysis demonstrated that TMPRSS2-ERG gene fusion correlated with the ethnicity (P=0.03), marginally correlated with the pathologic stage (P=0.06), but not other clinicopathologic parameters, including age, preoperative PSA levels, and Gleason score.

CONCLUSIONS

The prevalence and class of TMPRSS2-ERG are significantly different in PCa of Caucasian, African-American, and Japanese patients. Future studies of the molecular pathways implicated in TMPRSS2-ERG gene fusion may shed light on the disparity in prevalence and mortality of PCa among different ethnic groups and help design better prevention and treatment strategies.

摘要

背景

前列腺癌(PCa)在不同种族中的发病率和死亡率存在显著差异。其潜在的遗传学机制尚不清楚。TMPRSS2-ERG 融合是 PCa 中常见的染色体重排,但尚未在不同种族中进行研究。我们检测了来自白种人、非裔美国人和日本人的 PCa 中 TMPRSS2-ERG 基因融合的流行率和类型。

材料和方法

对 42 例白人、64 例非裔美国人和 44 例日本人接受根治性前列腺切除术(RP)的 PCa 组织微阵列进行了 TMPRSS2-ERG 融合研究,使用 ERG 基因断裂的多色间期荧光原位杂交检测 TMPRSS2-ERG 融合。

结果

TMPRSS2-ERG 基因融合存在于 50%(21/42)的白种人、31.3%(20/64)的非裔美国人和 15.9%(7/44)的日本人中(P=0.003)。基因融合通过易位、缺失或两者兼有发生在 61.9%(13/21)、38.1%(8/21)和 0%(0/21)的白种人、20%(4/20)、60%(12/20)和 20%(4/20)的非裔美国人以及 71.4%(5/7)、28.6%(2/7)和 0%(0/7)的日本人中(P=0.02)。多变量分析表明,TMPRSS2-ERG 基因融合与种族有关(P=0.03),与病理分期有边缘相关性(P=0.06),但与其他临床病理参数,包括年龄、术前 PSA 水平和 Gleason 评分无关。

结论

TMPRSS2-ERG 基因融合在白种人、非裔美国人和日本人的 PCa 中的流行率和类型存在显著差异。对 TMPRSS2-ERG 基因融合所涉及的分子途径的进一步研究可能有助于揭示不同种族间 PCa 发病率和死亡率的差异,并有助于制定更好的预防和治疗策略。

相似文献

1
TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients.TMPRSS2-ERG 基因融合在白种人、非裔美国人和日本前列腺癌患者中的流行率和类型有显著差异。
Prostate. 2011 Apr;71(5):489-97. doi: 10.1002/pros.21265. Epub 2010 Sep 28.
2
Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States.美国接受前列腺活检的男性中TMPRSS2-ERG融合前列腺癌的患病率。
Clin Cancer Res. 2009 Jul 15;15(14):4706-11. doi: 10.1158/1078-0432.CCR-08-2927. Epub 2009 Jul 7.
3
ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples.ETS 家族相关基因融合在日本前列腺癌中的研究:194 例根治性前列腺切除术样本分析。
Mod Pathol. 2010 Nov;23(11):1492-8. doi: 10.1038/modpathol.2010.149. Epub 2010 Aug 6.
4
TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort.在加拿大的一个队列中,TMPRSS2-ERG融合在 Gleason 3级前列腺癌中经常被观察到。
Cancer Biol Ther. 2009 Jan;8(2):125-30. doi: 10.4161/cbt.8.2.7134. Epub 2009 Feb 4.
5
TMPRSS2:ETS fusions and clinicopathologic characteristics of prostate cancer patients from Eastern China.中国东部前列腺癌患者的TMPRSS2:ETS融合与临床病理特征
Asian Pac J Cancer Prev. 2014;15(7):3099-103. doi: 10.7314/apjcp.2014.15.7.3099.
6
ERG rearrangement is present in a subset of transition zone prostatic tumors.ERG 重排存在于一部分移行区前列腺肿瘤中。
Mod Pathol. 2010 Nov;23(11):1499-506. doi: 10.1038/modpathol.2010.150. Epub 2010 Aug 6.
7
TMPRSS2-ERG gene fusion status in minute (minimal) prostatic adenocarcinoma.在微小(最小)前列腺腺癌中 TMPRSS2-ERG 基因融合状态。
Mod Pathol. 2009 Nov;22(11):1415-22. doi: 10.1038/modpathol.2009.121. Epub 2009 Sep 4.
8
Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers.TMPRSS2-ERG基因融合在淋巴结阳性前列腺癌中的患病率及预后意义
Prostate. 2014 Dec;74(16):1647-54. doi: 10.1002/pros.22882. Epub 2014 Sep 22.
9
Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues.前列腺癌中TMPRSS2与ETS家族基因之间的基因融合:通过对石蜡包埋组织进行RT-PCR和FISH分析其频率及转录本变体
Mod Pathol. 2007 Sep;20(9):921-8. doi: 10.1038/modpathol.3800903. Epub 2007 Jul 13.
10
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.TMPRSS2-ERG基因融合前列腺癌的形态学特征。
J Pathol. 2007 May;212(1):91-101. doi: 10.1002/path.2154.

引用本文的文献

1
A Brief Review of MicroRNA Profiling in Human Prostate Cancer Tissues and Plasma.人类前列腺癌组织和血浆中微小RNA谱分析的简要综述
Biomolecules. 2025 Aug 12;15(8):1156. doi: 10.3390/biom15081156.
2
Systems biology successes and areas for opportunity in prostate cancer.系统生物学在前列腺癌中的成功案例与机遇领域
Endocr Relat Cancer. 2025 Aug 20;32(8). doi: 10.1530/ERC-25-0067. Print 2025 Aug 1.
3
Human immune system: Exploring diversity across individuals and populations.人类免疫系统:探索个体和群体间的多样性。
Heliyon. 2025 Jan 13;11(2):e41836. doi: 10.1016/j.heliyon.2025.e41836. eCollection 2025 Jan 30.
4
Prostate cancers with distinct transcriptional programs in Black and White men.黑人和白人男性的前列腺癌具有不同的转录程序。
Genome Med. 2024 Jul 23;16(1):92. doi: 10.1186/s13073-024-01361-0.
5
Long Noncoding RNAs CAT2064 and CAT2042 may Function as Diagnostic Biomarkers for Prostate Cancer by Affecting Target MicrorRNAs.长链非编码RNA CAT2064和CAT2042可能通过影响靶标微小RNA发挥前列腺癌诊断生物标志物的作用。
Indian J Clin Biochem. 2024 Jul;39(3):322-330. doi: 10.1007/s12291-021-00999-6. Epub 2021 Aug 24.
6
A cross-sectional study of ERG expression and the relationship with clinicopathological features of Prostate cancer in Southwestern Uganda.乌干达西南部前列腺癌中 ERG 表达的横断面研究及其与临床病理特征的关系。
Diagn Pathol. 2024 May 10;19(1):67. doi: 10.1186/s13000-024-01494-1.
7
Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.与前列腺癌中 DNA 甲基化和雄激素受体相关的种族特异性共调控和转录组特征。
Genome Med. 2024 Apr 2;16(1):52. doi: 10.1186/s13073-024-01323-6.
8
Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review.精准医学时代前列腺癌发生发展的分子机制:综述
Cancers (Basel). 2024 Jan 25;16(3):523. doi: 10.3390/cancers16030523.
9
Genetic and biological drivers of prostate cancer disparities in Black men.导致黑人男性前列腺癌差异的遗传和生物学因素。
Nat Rev Urol. 2024 May;21(5):274-289. doi: 10.1038/s41585-023-00828-w. Epub 2023 Nov 14.
10
Acquired copy number variation in prostate tumours: a review of common somatic copy number alterations, how they are formed and their clinical utility.前列腺肿瘤中的获得性拷贝数变异:常见体细胞拷贝数改变的综述、其形成方式及其临床应用
Br J Cancer. 2024 Feb;130(3):347-357. doi: 10.1038/s41416-023-02485-7. Epub 2023 Nov 9.